0
0

Chapter 63. Treatment of Child and Adolescent Disorders

Karen Dineen Wagner, M.D., Ph.D.; Steven R. Pliszka, M.D.
DOI: 10.1176/appi.books.9781585623860.435382

Sections

Excerpt

This chapter focuses on the psychopharmacology of psychiatric disorders in children and adolescents. However, nonpharmacological treatment interventions are also an important component of a child's psychiatric care. Individual psychotherapy, group therapy, and family therapy may improve clinical outcome. Working closely with school personnel is another ingredient in the treatment of a child with a psychiatric disorder. Case management for the child and support for the family are other facets of treatment for children.

Your session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

References

+

CME Activity

Add a subscription to complete this activity and earn CME credit.
Sample questions:
1.
Which of the following medications has been approved by the U.S. Food and Drug Administration (FDA) to treat major depression in children?
2.
According to treatment guidelines developed by expert consensus and review of the available treatment literature, all of the following are recommended first-line agents for children and adolescents with bipolar I disorder except
3.
For treatment of obsessive-compulsive disorder (OCD) in children, which of the following medications is generally considered to be a third-line option, either as monotherapy or augmentation?
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Related Content
Articles
Books
DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders > Chapter 1.  >
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 11.  >
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 14.  >
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 25.  >
Helping Parents, Youth, and Teachers Understand Medications for Behavioral and Emotional Problems: A Resource Book of Medication Information Handouts, 3rd Edition > Chapter 31.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
 
  • Print
  • PDF
  • E-mail
  • Chapter Alerts
  • Get Citation